Back
Meta Platforms Vs. Akero Therapeutics Industry Stock Comparison
Buy
80
META
Meta Platforms
Last Price:
$689.00
Seasonality Move:
7.79%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Buy
80
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
-
The current Meta Platforms [META] share price is $689.18. The Score for META is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
META is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.08. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $689.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
META Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.63 | Buy |
Relative Strength Index (14 RSI): | 74.58 | Buy |
Chaikin Money Flow: | -12002932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (595.07 - 654.59) | Buy |
Bollinger Bands (100): | (554.53 - 623.53) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.25 | Buy |
Relative Strength Index (14 RSI): | 82.91 | Buy |
Chaikin Money Flow: | -280479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.47 - 42.61) | Buy |
Bollinger Bands (100): | (24.31 - 36.07) | Buy |
META Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 661.79 | Buy |
20-day SMA: | 631.65 | Buy |
50-day SMA: | 609.95 | Buy |
200-day SMA: | 540.65 | Buy |
8-day EMA: | 665.03 | Buy |
20-day EMA: | 640.42 | Buy |
50-day EMA: | 615.63 | Buy |
200-day EMA: | 544.17 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43 | Buy |
20-day SMA: | 32.36 | Buy |
50-day SMA: | 31 | Buy |
200-day SMA: | 26.7 | Buy |
8-day EMA: | 45.65 | Buy |
20-day EMA: | 36.88 | Buy |
50-day EMA: | 32.36 | Buy |
200-day EMA: | 28.76 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.30 per share, an increase this year of $2.63 per share, and an increase next year of $3.83 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Meta Platforms Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |